5-(2-Methoxyphenyl)isoxazole-3-carboxylic acid

Catalog No. :
ACVOKS239
CAS No. :
668971-16-2
Molecular Formula :
C11H9NO4
Molecular Weight :
219.20

IUPAC Name:5-(2-methoxyphenyl)isoxazole-3-carboxylic acid

5-(2-Methoxyphenyl)isoxazole-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$155.00Login to see priceIn stockInquiry
1g95%$402.00Login to see priceIn stockInquiry
5g95%$1181.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(2-Methoxyphenyl)isoxazole-3-carboxylic acid
IUPAC Name5-(2-methoxyphenyl)isoxazole-3-carboxylic acid
MDL No.0
Molecular FormulaC11H9NO4
Molecular Weight219.20
SMILESCOC1=C(C=CC=C1)C1=CC(=NO1)C(O)=O
InChI KeyUDFIWFVAYAOMRF-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB011406;5-(2-methoxyphenyl)-1,2-oxazole-3-carboxylic acid;ASINEX-REAG BAS 11730012;5-(2-METHOXY-PHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID;5-(2-METHOXYPHENYL)-3-ISOXAZOLECARBOXYLIC ACID;3-isoxazolecarboxylic acid, 5-(2-methoxyphenyl)-;5-(2-methoxyphenyl)isoxazole-3-carboxylic acid(SALTDATA: FREE)
CAS No.668971-16-2
PubChem CID6484427

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P264-P302+P352-P304+P340-P305+P351+P338-P332+P313-P337+P313

Synthetic Route by SureRoute

1. ACVOKS239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSVYE659 route compound structure diagram
    ACSVYE659579-74-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVOKS239 route product structure diagram
    ACVOKS239668971-16-2 In Stock
Inquiry

2. ACVOKS239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVOKS239 route product structure diagram
    ACVOKS239668971-16-2 In Stock
Inquiry

Comments (0)